Skip to main content

Table 4 Effect of SFC therapy on the levels of cytokines in the blood of COPD

From: Relationship between the anti-inflammatory properties of salmeterol/fluticasone and the expression of CD4+CD25+Foxp3+regulatory T cells in COPD

 

Baseline

SFC therapy

IL-17A (ng/ml)

1.06 ± 0.06

0.95 ± 0.06*

TNF-α (pg/ml)

212.88 ± 13.10

148.97 ± 14.33**

IL-8 (ng/ml)

9.97 ± 0.43

7.53 ± 0.40***

IL-10 (pg/ml)

47.43 ± 7.71

50.59 ± 6.17

  1. * p < 0.05, ** p < 0.01, *** p < 0.001
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us